Form 8-K - Current report:
SEC Accession No. 0001193125-24-251673
Filing Date
2024-11-06
Accepted
2024-11-06 06:45:29
Documents
15
Period of Report
2024-11-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d781927d8k.htm   iXBRL 8-K 27714
2 EX-99.1 d781927dex991.htm EX-99.1 4992
6 GRAPHIC g781927g1105215451290.jpg GRAPHIC 2270
  Complete submission text file 0001193125-24-251673.txt   161266

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cvs-20241106.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvs-20241106_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvs-20241106_pre.xml EX-101.PRE 10815
18 EXTRACTED XBRL INSTANCE DOCUMENT d781927d8k_htm.xml XML 3520
Mailing Address ONE CVS DR. WOONSOCKET RI 02895
Business Address ONE CVS DR. WOONSOCKET RI 02895 4017651500
CVS HEALTH Corp (Filer) CIK: 0000064803 (see all company filings)

EIN.: 050494040 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01011 | Film No.: 241429165
SIC: 5912 Retail-Drug Stores and Proprietary Stores
(CF Office: 07 Trade & Services)